Peer Review History
| Original SubmissionJuly 26, 2019 |
|---|
|
PONE-D-19-21084 Clinical ethics consultation among Italian Ethics committee: a mixed method study PLOS ONE Dear Ludovica De Panfilis, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Dec 02 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Kelly Holloway Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. Additional Editor Comments (if provided): 1. The most significant revision required is that you clarify how your data suggests the "need to set up institutional bodies dedicated to ethical matters, composed by experts with a specific competence in ethical issues." Currently your data does not seem to show this. You need to more clearly establish a connection between your findings and this conclusion. 2. Please rewrite the abstract: -Spell out acronyms like REC and EC. -Can you clarify what this means? "Review of the policies promoted by ECs showed that 72,6 % (n=69) of all the ECs (N=95) being actually capable of providing ethics consultation service by policy." The meaning is unclear. What policy are you referring to? -Can you clarify this sentence? "To date, ethics consultation in clinical and research practice is largely underappreciated and NOT WELL? understood by users." It seems that you are arguing that it is underappreciated and it IS understood. I don't think this is what you mean. -This sentence does not make sense: "Despite research THAT? clinical ethics consultation services should not necessarily be mandatory, following the recent EU Regulation on clinical trials, institutional ethics consultation bodies should be re-evaluated. [END THE SENTENCE HERE.THE REST IS REDUNDANT] in perspective of application of new regulations." 3. Please clarify why it is worth mentioning the Friuli Venezia Giulia Region in the reporting of the ECs with a policy on ethics consultation. 4. Please rewrite this sentence on line 268: "The 23 ECs that did not perform ethics consultation by policy declared that they were supported by alternative structures, except for six ECs that did not provide ethic consultation and were not supported by any alternative body/structure." Do you mean 17 ECs that did not perform ethics consultation by policy declared that they were supported by alternative structures?? 5. The following section of the discussion is unclear: "Interestingly, the interviews and surveys led us to cover [NOT SURE WHAT YOU MEAN BY COVER] the definition of consultations despite THE FACT THAT? this was a direct question IN our survey or interviews. DEFINITIONS OF ETHICS CONSULTATION provided by participants, WERE in agreement with the Ministerial Decree of February 8, 2013 as any activity concerning ethical issues related to scientific and clinical activities, aiming at protecting and promoting a persons’ value (9)." It is not clear what you mean by including this section on the definition of ethics consultation. How is this related to the research question/ study design? [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I would consider the manuscript just sufficient and even if not completely well done it is acceptable for publication. About the survey through the use of questionnaires, few results are not so clear and precise like, as reported at Tab.2 (line 220), the definition of Clinical centers and the number of 6 for Ethics Committese in the Veneto Region (in fact in the Veneto Region the Ethics Committes are more than 6: the authors must clarify if they take in account only the RECs or also the CECs). The number of interviews is very low and therefore it is difficult to have significant conclusions. It should be better explained the use of the concept of the Clinical Ethics Consultation and in this context it is important to quote the recent Italian publications (as the Declaration of Trento). About the references, ref. nr. 3, line 384; ref. nr. 16, line 410-411, are not completed and quotations for the US Belmont Report and the Italian literature about clinical ethics consultation and ethics committees are missing. Reviewer #2: To be of interest to a broader audience, it is suggested that the authors delineate the rationale for their work more clearly. They have assumed the reader has detailed knowledge of the EU regulations (this reviewer has read this particular EU regulation 536/2014) but does not draw any parallels between that regulation and the current submitted work. For example the justification for this work seems to be that the "its effect is far reaching and will likely effect aspects such as the role and function of ethics consultations". This is not sufficient most readers and certainly would be important to justify the current work to draw out the section in the current regulation that is pertinent. The impact, importance and why this work is of interest to a broader audience is lacking upfront. The survey methods, and survey itself and reporting are done are done with rigor and high quality. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-19-21084R1 Clinical ethics consultation among Italian Ethics committee: a mixed method study PLOS ONE Dear Dr. De Panfilis, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== We would appreciate receiving your revised manuscript by Jan 10 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Kelly Holloway Academic Editor PLOS ONE Additional Editor Comments (if provided): Unfortunately the revised paper does not address the central concern expressed in the most recent revision; that the data does not support the conclusion. The data shows: -According to a review of policies, 72.6% of ECs provide ethics consultation (And 52.1% of them received no requests for ethics consultation in 2016). -According to the survey, 67.6% ECs provide ethics consultation. -Qualitative interviews with four people indicated that the team should be interdisciplinary, and that HPs perform ethics consultation informally. Further, "HPs could not benefit from specific training programs, and often lack information about the existing services and its activities." I fail to see how this data supports the idea that there should be institutional bodies composed by experts who a specific competence in ethical issues. Who are these experts? Where have they been identified in the study? The authors must significantly revise the conclusion in order to reflect the findings. As it stands, the data does not support “the need to set up institutional bodies dedicated to ethical matters, composed by experts with a specific competence in ethical issues.” [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Clinical ethics consultation among Italian Ethics committee: a mixed method study PONE-D-19-21084R2 Dear Dr. De Panfilis, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Kelly Holloway Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-19-21084R2 Clinical ethics consultation among Italian Ethics committee: a mixed method study Dear Dr. De Panfilis: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Kelly Holloway Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .